A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
Views: 4204
2023-11-28 19:45
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Crypto Altcoins Outperform as Ripple Court Ruling Spurs FOMO
Ford, SK joint venture set to receive $9.2 billion US government loan for battery plants
Is Silent Hill 2 Remake Coming to Xbox?
Nokia renews patent license agreement with Apple, covering 5G and other technologies
Police Raid Consulting Firm as China Starts Anti-Spy Campaign
Games with Gold losing Xbox 360 games from October 2022
Tencent, Sony to take stake in "Elden Ring" publisher FromSoftware
Diablo 4 Sales Top $666 Million After Launch Week